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INTRODUCTION
Fifty years ago bacterial meningitis was studied intensively in both labora-
tory and clinic. Many illustrious investigators-Councilman, Flexner,
Austrian, Wollstein, and Weed, to mention a few-lent themselves to the
task of elucidating the pathogenesis, anatomical changes, and pathological
physiology associated with these infections and devising effective forms of
treatment for this almost invariably fatal disease. With the advent of anti-
biotics the outlook for patients with meningeal infections improved con-
siderably, and concomitantly studies on experimental meningitis almost
disappeared from the literature. It is significant that in a recent symposium
on the cerebrospinal fluid a discussion of experimental meningitis was con-
spicuously absent.9' In contrast to most other bacterial infections, how-
ever, nearly one quarter of patients with meningitis die despite optimal
therapy with antibiotics.' The reason for this persistent mortality is not
clear but stems in part, at least, from inadequate knowledge of the manner
in which microbes produce infection within the subarachnoid space-their
portal of entry, rate of growth, mode of dissemination within neural struc-
tures, action upon the normal exchange of metabolites between blood and
cerebrospinal fluid, effect upon essential enzyme systems, and the mech-
anism by which they produce death. In our present state of knowledge,
answers to most of these questions are not available.
It is the purpose of this brief review to assemble the pertinent informa-
tion on the pathogenesis and physiology of meningitis, correlate it with
certain phenomena observed clinically and raise questions which may lead
to sound basic and clinical investigation of the mysteries beclouding the
nervous system's response to infection. We have purposely limited the dis-
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cussion to acute bacterial meningitis and have restricted the references to
pertinent experimental papers, omitting most clinical reports. This does
not imply, of course, that bacterial meningitis serves as the prototype for
infections of the pia-arachnoid by other agents. It is hoped, however, that
an analysis of the factors mediating meningeal infections by bacteria may
stimulate further thought and experimentation on the effect of other in-
jurious stimuli, biological or physical, on the coverings of the nervous
system.
EXPERIMENTAL MENINGITIS
A. General considerations. The earliest attempts to produce experimental
meningitis in animals utilized infected cerebrospinal fluid from patients
to establish an etiologic relationship and to fulfil Koch's postu-
lates.'6 "41 52,UO.1,1 After it had been demonstrated conclusively that a
number of common pathogenic bacteria such as the pneumococcus, meningo-
coccus, and Hemophilus influenzae were capable of causing lethal inflam-
mation of the meninges, meningitis in animals was employed experimentally
to evaluate therapeutic regimens including serum,"' "" subarachnoid lavage
with antiseptic agents,' antibiotics,'-l' and proteolytic enzymes."
One of the difficulties in interpreting the mass of experimental data in
this field, has been the failure to achieve a standardized, reproducible ex-
perimental model such as acute pyelonephritis in rats,' pneumococcal peri-
tonitis in rabbits,15 or staphylococcal disease in mice.
Before embarking upon a review of the literature, it seems worthwhile
to propose certain definite criteria for the ideal infection to use as a stand-
ard of reference for comparison with previous studies:
1. The portal of entry and route of dissemination of the organism must
be akin to those in man.
2. The parasite must be pathogenic for man as well as experimental
animals.
3. The course of the disease must be relatively predictable and of suffi-
cient duration to permit evaluation of therapy.
4. The disease must be reproducible within the limits of biological varia-
tion.
5. The lesions in the experimental infection must be morphologically
similar to those in man.
6. The technique must be relatively simple.
Unfortunately, no single investigation has fulfilled these requirements,
and, indeed, many questions need be answered before the criteria enumer-
ated can be met. Our lack of understanding concerning the pathogenesis
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of infections of the nervous system has led to many artificial studies in
which the investigator has designed the experimental setting to conform
to the expected results. Many of these investigations, however, furnish
valuable clues which may not always supply direct answers but provide
topics for further discussion and experimentation.
B. Relationship between route of infection and development of meningitis.
The hypothesis that bacteremia per se may be attended by meningitis was
examined with a variety of organisms. The early claims of Bull"' and
Elser and Hutoon" that meningitis follows the intravenous inoculation of
bacteria have not been substantiated." 7 3 192 As might be expected, the
more remote intraperitoneal route has also failed to yield meningeal infec-
tion."" A single attempt to infect the central nervous system by direct
injection of organisms into the carotid artery was unsuccessful.'
A more rational approach, predicated upon the clinical finding that
meningococci were frequently harbored in the nasal passages of patients
with meningococcal meningitis, consisted of the direct application of bac-
teria to the nasal mucosa of animals. However, meningitis did not
occur.7' ',ue It has long been evident that infections of the paranasal sinuses,
middle ear, and mastoids can spread to the meninges. Attempts to dupli-
cate this phenomenon in cats were only intermittently successful.' Fur-
thermore, even in this study physical irritants such as iodine and mustard
oil were used to facilitate passage from the frontal sinus to the meninges.
Osteomyelitis was a frequent accompaniment of sinusitis in this experi-
mental model, and it is conceivable that the bone rather than the sinus
cavity served as the infecting focus. Southard and Keene were able to
infect the meninges by intraorbital inoculation of bacteria,'62 but it is not
clear from their report whether the injections were intraorbital or, in fact,
intracerebral.
These studies indicate that the nervous system is admirably protected
from infection by microorganisms in the blood stream and do little to
establish the importance of "neighborhood infection" in the pathogenesis
of meningitis. Furthermore, neither method has provided a suitable model
for evaluating therapy.
More success has followed injection of bacteria directly into the lumbar
subarachnoid space. Of historic interest are the studies of Councilman
et al. who infected a goat by this route." Subsequently, other investiga-
tors have utilized this method with a variety of organisms and spe-
cies.7 61 8, 2 Even man has served as an accidental subject in experiments
of this type when clinical meningitis has followed lumbar puncture for
spinal anesthesia and intrathecal therapy.' The offending organism is
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usually one of the Gram-negative enteric bacilli, chiefly Pseudomonas
aeruginosa. Stanley has reported 32 cases of iatrogenic Pseudomonas men-
ingitis with a mortality of 40 per cent.'
In experimental animals a number of difficulties have been inherent in
the installation of organisms directly into the lumbar sac. Firstly, the lack
of predictability of the course of infection made response to therapy difficult
to ascertain.62 For example, Flexner, employing meningococcus, was
impressed with the acute course of the disease.6' On the other hand,
Lamar"" and Idzumi6 were able to produce a protracted illness with the
pneumococcus. Death in the acute cases was probably due to bacteremia,
but bacteriological confirmation of this was sparse. Secondly, spinal cord
injury has been frequent and bacteria have often been injected into the
cord." Lastly, the small size of the lumbar sac in most species has led
to inaccurate placement of bacterial inocula as well as a paucity of spinal
fluid for serial studies.
Some of these objections can be overcome by employing suboccipital
puncture with introduction of bacteria into the cisterna magna. The tech-
nique of cisternal puncture was first employed in animals by Dixon and
Halliburton in 191348 and in man by Wegeforth et al."02 several years later.
Subsequently, this method was used extensively because of the accessi-
bility of the subarachnoid space in this area and the ease with which re-
peated samples of spinal fluid can be obtained.'8"9' 20 S,93,104,145,16,6,178,202
The main disadvantage of this experimental model is the frequent occur-
rence of bacteremia and early death,"10" 145"N
I raising the question whether
death in these animals was a consequence of the inflammatory changes in
the neuraxis or overwhelming sepsis. A similar problem may, in fact, exist
in man, and Daniels has postulated that death in meningococcal meningitis
was related to the "toxic" effect of bacteremia as much as meningitis.'
This conflicts with the findings of Alexander et al., who state that mortality
in pneumococcal meningitis could not be correlated with bacteremic spread.'
The prognostic implication of bacteremia in clinical meningitis deserves
further study.
In animals, in addition to the acute septicemic form, the intracisternal
instillation of bacteria may be followed by a chronic indolent infection of
the meninges.M '' The persistence of the inflammatory process may be
related to subarachnoid blockage by large quantities of exudate or to the
development of abscesses within the parenchyma of the spinal cord.'
Since many of these infections were created for the purpose of analyzing
some specific therapeutic regimen, the chronic exudative type is to be pre-
ferred to the acute septic type. Unfortunately, there is no way to predict
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in the individual animal which course the infection will follow. By inject-
ing ground jellied agar in combination with Pseudomonas aeruginosa, Ham-
burger was able to achieve a chronic exudative infection regularly.' An-
other group of animals infected intracisternally have had a relatively pro-
longed illness terminating in recovery or death. However, exudation was
not a feature of their disease and at autopsy only minimal morphological
changes were present in the nervous system but, interestingly enough,
heart blood cultures were positive. Although endocarditis was not de-
scribed, one wonders whether it may have been present. The course of
these animals is reminiscent of that of patients who recover from pneumo-
coccal meningitis only to succumb to endocarditis.8
Minor difficulties which have been encountered with the intracisternal
route are extravasation of the inoculum into the surrounding soft tissues
and direct trauma to the medulla oblongata.1"
Intradural administration of bacteria through a trephine is another tech-
nique for infecting the meninges.33'1" This method affords increased accur-
acy by permitting direct visualization of the meninges but is somewhat
tedious. Manwaring attempted placement of virulent tubercle bacilli into
the basilar cisterns by puncturing the frontal lobes with a long needle.'
As pointed out by Austrian,' however, this maneuver was accompanied by
extensive damage to cerebral parenchyma.
Compared to its extensive use in the investigation of neurotropic viruses,
direct intracerebral inoculation of bacteria has been used rarely."'-'-'
In most animals, either transient neurological disturbances or a diffuse
cerebritis with fulminating septicemia are observed. Localization of the
infection with abscess formation was possible only when the cerebral paren-
chyma was injured by needle puncture several days before bacteria were
reinjected into the site of previous trauma.'''
Flexner and Amoss performed a series of classical experiments in mon-
keys in which the combination of sterile aseptic meningitis and viremia was
used to induce clinical poliomyelitis." In a number of studies in which
bacteria rather than viruses were given intravenously following aseptic
meningitis, meningeal infection occurred only sporadically.' ' ' 181 Sterile
inflammation of the meninges can regularly be observed following the in-
trathecal administration of saline, serum, and a variety of other substances
and probably enhances the passage of pathogens from blood to nervous
system. Clinically it appears to be of little significance since bacterial super-
infection in patients with aseptic meningitis is rare.
The studies described thus far do not elucidate the train of events in
the pathogenesis of meningeal infections in man and, except for meningitis
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secondary to a neighboring focus and iatrogenic infection following lumbar
puncture, have little applicability to human disease. While there is no
direct evidence that microorganisms reach the meninges via the blood
stream, the frequency with which meningeal infection is preceded by bac-
teremia suggests that the hematogenous route may be an important path-
way by which bacteria reach the nervous system. This thesis gains support
in the studies of Weed et al., relating alterations in cerebrospinal fluid
dynamics during experimental bacteremia to the development of menin-
gitis."79"8' When cerebrospinal fluid was removed from cats immediately
preceding or following the intravenous introduction of a virulent culture
of B. lactis aerogenes, generalized leptomeningitis developed, usually within
24 hours. Control animals given twice the intravenous dose invariably
remained well. B. lactis aerogenes was used in the majority of experi-
ments, but infection could be produced by several other bacterial species.
This phenomenon did not appear to be peculiar to the cat since other
animals could also be infected.
The obvious explanation for these results is that trauma to small menin-
geal blood vessels at the time of lumbar or cisternal puncture provided
access for bacteria but careful morphological studies failed to substantiate
this.9 Furthermore, infusion of hypertonic solutions, compression of the
jugular veins, and transient cardiac standstill during bacteremia were also
followed by meningitis, indicating that direct injury to nervous structures
was not a sine qua non in the development of this infection.'8' Weed postu-
lated that the occurrence of infection was facilitated by the transient lower-
ing of cerebrospinal pressure associated with these procedures. Unfortu-
nately, there are no data to support this hypothesis because no accurate
measurements of spinal fluid pressure were made. Since jugular compres-
sion, which is usually attended by an abrupt rise in cerebrospinal fluid
pressure, had the same effect as procedures which presumably resulted in
cerebrospinal hypotension, one wonders whether the rate of change rather
than the direction may not be of importance. A crucial experiment would
be to determine whether the re-injection of cerebrospinal fluid following
its removal during bacteremia would prevent meningeal infection. Unfor
tunately, data on this point are scanty.
The applicability of Weed's experiments to the pathogenesis of the dis-
ease in man is difficult if not impossible to determine. Even if it were postu-
lated that bacteremia antedated meningitis under natural conditions, the
magnitude of change in spinal fluid dynamics might be insufficient to facili-
tate infection. Of more clinical significance is the possible danger of diag-
nostic lumbar puncture during bacteremia. Wegeforth and Latham per-
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formed lumbar punctures in 93 patients with suspected meningitis.'8 In
55 of these, the cerebrospinal fluid was normal. Six patients had meningo-
coccemia or pneumococcal bacteremia at the time of lumbar puncture, and
five of the six subsequently developed meningitis. On the basis of these
findings, the authors condemn diagnostic lumbar puncture in the absence
of strong clinical indications. Remsen shared this viewpoint and added a
case of streptococcal meningitis occurring under similar circumstances.'
It seems likely that these few cases are not representative of the over-all
clinical experience, and that the occurrence of meningitis following lumbar
puncture during bacteremia is relatively rare. Pray lends support to this
by presenting evidence that the incidence of meningitis in children with
pneumococcal bacteremia is not increased by lumbar puncture.' Com-
pared to the risk of missing the diagnosis of meningitis by omission of
lumbar puncture, the chance of developing meningitis following the pro-
cedure is small even in the presence of bacteremia, and there are not suffi-
cient data to consider "suspected or documented sepsis" as a contraindica-
tion to lumbar puncture.
Although not strictly pertinent to the subject of acute bacterial meningi-
tis, the studies of Rich and McCordock based upon some of these early
negative experiments deserve mention.1' These investigators noted a
rather persistent discrepancy between the age of the visceral lesions in
miliary tuberculosis and the tubercles in the meninges, the latter appearing
more acute than the former. This finding suggested to them that the
meninges were probably not seeded with tubercle bacilli by the hema-
togenous route. Furthermore, they were consistently unable to produce
meningitis by the intravenous injection of virulent tubercle bacilli into
hypersensitive animals despite the fact that massive visceral tuberculosis
invariably developed. On the other hand, intrathecal administration of
acid-fast organisms resulted in infection of the meninges. These experi-
ments indicated that the pia-arachnoid was infected from contiguous foci
in the underlying cerebral parenchyma, and this impression was confirmed
by the finding of tuberculomata in the cerebral cortices of 77 of 82 patients
with tuberculous meningitis. Unfortunately, no such clinicopathological
relationships have been derived in acute bacterial meningitis, and it is not
known whether infected CSF serves as a focus for infection of the brain
and spinal cord or whether the reverse situation obtains.
C. Causative pathogen. Meningitis in animals has been produced experi-
mentally by most of the organisms which cause the disease in man. The
common human pathogens D. pneumoniae, N. intracellularis, H. influenzae,
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and Staph. aureus have been used most often. Gram-negative enteric
bacilli have been the subject of a few studies.'" 7 181
In man there is good correlation between the etiological pathogen and
the clinical setting. Thus, pneumococcal meningitis is frequently a sequel
to infection of the paranasal sinuses, mastoids, and pleural space; the men-
ingococcus tends to produce a fulminating illness in an epidemic setting;
hemophilus shows predilection for children, staphylococcal meningitis is
prone to occur with cavernous sinus thrombosis or epidural abscess, and
Klebsiella meningitis is most often seen in diabetics or after head
trauma."",173a Similar differences have been noted in some animal experi-
ments. Although different animals were employed, pneumococcal meningi-
tis8"" appears to run a more protracted course than the disease produced
by the meningococcus.'1 Stewart found that type II pneumococcal meningi-
tis was characterized by formation of a heavy fibrin exudate and rapid
development of subarachnoid block, while type I caused a septicemic ill-
ness associated with minimal exudation.1"7"1
Most cases of iatrogenic meningitis are caused by Gram-negative organ-
isms rather than other human commensals.' This observation in conjunc-
tion with experimental evidence suggests that Gram-negative bacteria may
possess a high degree of virulence for the meninges.' The capacity of these
organisms to elaborate an endotoxin may account for the increase in viru-
lence. Pertinent to this point are the studies of Branham and co-workers
in rabbits which suggest that the damage to the meninges following injec-
tion by the intracisternal route may be due to a toxic product of the patho-
genic bacterium rather than the intact organism."'l They found that puru-
lent or fibrinopurulent meningitis occurred with living meningococci as
well as organisms which had been boiled or passed through a Berkefeld
N filter and they were unable to distinguish clinically or pathologically
between the infections produced by the different preparations. Direct in-
stillation of highly purified endotoxin from Salmonella abortus equi and
Shigella flexneri (type Z) into the cisterna magna of dogs also resulted in
marked cerebrospinal fluid pleocytosis.'4"
The virulence of the infecting organism is enhanced by serial intra-
meningeal passage.'
' In this respect the meninges resemble other
tissues. This phenomenon is independent of the species and organism em-
ployed. Its clinical significance in man is unknown.
D. Susceptible host. Meningitis occurs naturally in a wide variety of ani-
mals. For example, spontaneous meningococcal and pneumococcal menin-
gitis has been described in horses, calves, and goats; young animals appear
to be more vulnerable.' Pseudomonas has been incriminated as a cause
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of meningitis in pigs with infectious rhinitis.1" In view of the wide natural
host range of meningeal infections, it is not surprising that the disease has
been produced with ease in guinea pigs, rabbits, monkeys, dogs, and cats.
The last two lend themselves well to experimentation. Their relatively
large size minimizes the difficulty of lumbar puncture encountered in smaller
species and also furnishes an adequate amount of spinal fluid for examina-
tion. Rabbits are poor experimental subjects since many have sustained
cord damage at time of lumbar puncture and cerebrospinal fluid has been
difficult to obtain in sufficient quantity. This species is also highly suscep-
tible to the lethal effect of bacteremia with certain organisms." " 1
Different species may be particularly resistant to bacterial infection with
certain organisms. For example, the dog tolerates pneumococcal meningitis
better than the rabbit."' There is little other information concerning differ-
ences in the susceptibility of individual species to infection of the meninges.
THE EFFECT OF INFLAMMATION ON THE PERMEABILITY OF THE MENINGES
A. General considerations. The mechanisms controlling the passage of
substances in and out of the nervous system are complex and poorly under-
stood. Functionally, two sites of exchange have been postulated. One,
which encompasses the entire neuraxis, is concerned with a transfer of
organic and inorganic materials between the plasma and the cerebrospinal
fluid-the blood-cerebrospinal fluid barrier. The other, termed the blood-
brain barrier, is the locus of interchange between the blood stream and
neural parenchyma. The anatomical location of these two barriers, their
relationship to one another, and their basic physiological actions are con-
troversial and not germane to the present discussion. Suffice it to say, both
are profoundly altered by inflammation of the meninges. These changes in
permeability may contribute to the aberrations of the spinal fluid in menin-
gitis and may affect the course of the disease. Finally, the passage of drugs
into the nervous system is controlled to a large extent by these barriers
and any variation in the entry of chemotherapeutic agents is of obvious
importance. In the following section, the effect of inflammation on the
permeability of these barriers to a variety of exogenous and endogenous
substances will be discussed.
B. Exogenous substances. 1. Inorganic ions. A number of inorganic sub-
stances normally not found in the spinal fluid have been given to patients
and animals with meningitis to determine whether they could be recovered
in the spinal fluid. Of the many anions tested,'T studies with bromide""1l
and radioactive phosphorus'8 have been most valuable. The bromide test
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involves the oral or intravenous administration of sodium bromide followed
by simultaneous measurements of this ion in the serum and spinal fluid
after equilibrium is established. Normally the ratio between blood and
cerebrospinal fluid bromide is 2.6 and remains remarkably constant. With
the development of meningitis, the ratio approaches unity and rises again
as healing takes place.",172
The distribution of radioactive phosphorus (P") has been measured in
experimental staphylococcal and streptococcal meningitis in rabbits.'
Within 24 to 36 hours after the induction of infection, the P'2 concentra-
tion in the cerebrospinal fluid of animals with meningitis was three times
that of the controls. The P" concentration in the cerebral parenchyma had
risen two-fold.
2. Dyes. The historic observation of Goldmann that trypan blue given
parenterally was unable to penetrate into the nervous system initiated the
concept of the blood-brain barrier and prompted investigation of a number
of organic dyes as indicators of meningeal permeability.7' Koyama reviewed
the passage of 52 dyes into the cerebrospinal fluid of rabbits and found
that their concentration was increased in meningitis.'
Sodium fluorescein (Uranin) also lends itself to measurement of the
integrity of the blood-cerebrospinal fluid barrier. Following oral or paren-
teral administration, little is found under normal conditions, but it is readily
detected in patients with bacterial or tuberculous meningitis."7 ""'M Simi-
lar results have been reported in syphilis of the nervous system.'
Of interest are a few experiments in which organic dyes were utilized
to determine passage from the spinal fluid to the blood, and it is note-
worthy that some substances which gain access from blood to cerebrospinal
fluid with difficulty pass in the reverse direction with ease. Thus, trypan
blue given intrathecally is detectable in the blood stream shortly after in-
stillation.' Similarly, normal infants given phenolsulfonphthalein (PSP)
intrathecally excrete the dye in the urine shortly thereafter." Limited
studies suggested that intrathecal PSP may be retained in the subarach-
noid space when the meninges become involved by disease.' This might
be of clinical significance since therapeutic agents might be handled in simi-
lar fashion.
3. Toxic products of bacteria. It is conceivable that the ability of bac-
teria to cause infections in the nervous system is related not to their in-
vasiveness but rather to the ability to elaborate endotoxins which might
facilitate their passage from blood to brain. This may account for the men-
ingeal virulence of B. lactis aerogenes described by Weed, and, more im-
portantly, for the propensity of Neisseria intracellularis to cause meningitis:
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The intracarotid administration of endotoxin has been shown to enhance
the passage of fluorescein into the brain of the rabbit.5' When the toxin
was given intravenously, there was also some increase in passage of the
dye from blood to CSF although this occurred only after a lag period of
two hours.1' On the other hand, administration of typhoid vaccine to dogs
four hours preceding the intravenous injection of pneumococci, followed by
lumbar puncture, did not increase the incidence of pneumococcal meningi-
tis in these animals.' These experiments are far from conclusive, and the
role of endotoxins in the pathogenesis of bacterial meningitis deserves fur-
ther study. In contrast to endotoxins of Gram-negative bacteria, the exo-
toxins of diphtheria, tetanus, and staphylococcus were not injurious to the
blood-brain barrier.'
4. Drugs. The passage of drugs into the spinal fluid under normal and
abnormal conditions has received intensive study. The present discussion
will limit itself to the passage of antimicrobial agents in meningitis. Aseptic
meningitis facilitated the passage of arsphenamine into the cerebrospinal
fluid' but did not enhance its deposition in the brain or spinal cord.'
Binding by plasma proteins limits the ingress of sulfonamides into the
spinal fluid, but usually sufficient quantities enter to achieve theoretically
adequate therapeutic levels.' Sulfanilamide penetrates into the cerebro-
spinal fluid most effectively, and, after equilibrium has taken place, the
cerebrospinal fluid concentration is equal to that of the blood.'
Since penicillin is the drug of choice in the treatment of Gram-positive
coccal meningitis, its passage into the cerebrospinal fluid has received wide
attention. Many studies employing small dosages of the drug attest to the
relative impermeability of the blood-cerebrospinal fluid barrier to penicil-
lin."''6 "' When large amounts of penicillin are given parenterally, there
seems to be a slight increment in the amount of drug found in the cerebro-
spinal fluid, but this is not a linear relationship.'6' "' The data provided
by these studies are limited and require confirmation. Fortunately, there
is general agreement that transfer of penicillin from blood to spinal fluid
is increased in meningitis.""' Little is known about cerebrospinal fluid
level of the drug during acute infections, but the striking decrease in mor-
tality observed with the use of this drug provides prima facie evidence that
in the majority of cases therapeutically effective concentrations are reached.
Based on a comparison with several series of patients with pneumococcal
meningitis treated with parenteral penicillin it can be concluded that the
addition of the drug intrathecally does not exert a major effect.'' How-
ever, in occasional patients with peripheral circulatory collapse, intrathecal
administration may offer a distinct advantage.
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Under normal conditions streptomycin does not diffuse readily into the
cerebrospinal fluid, but its passage is enhanced by meningeal inflamma-
tion."' Although it was once considered necessary to administer strep-
tomycin intrathecally, this practice is distinctly hazardous and should be
avoided.2"'191 Fortunately, the advent of isoniazid in the treatment of
tuberculous meningitis and chloramphenicol for infections caused by H.
influenzae has led most clinicians to abandon the use of intrathecal strep-
tomycin. There is little doubt, however, that prior to utilization of massive
parenteral chemotherapy, and the advent of more effective drugs, the direct
instillation of antimicrobials into the subarachnoid space was often life-
saving.124a
The tetracyclines are capable of traversing the blood-cerebrospinal fluid
barrier, tetracycline being the most diffusable and oxytetracycline the
least. Normally, the tetracycline level in the cerebrospinal fluid is one-
tenth of that in the blood.'24 Infection enhances the permeability of the
meninges to oxytetracycline and, presumably, to the others in this group.'Z
Chloramphenicol is regularly detected in the cerebrospinal fluid when
blood levels greater than ten micrograms per ml. are reached, and the con-
centration in the spinal fluid is approximately 25 per cent of that in the
blood.1"4 The availability of chloramphenicol as the highly soluble succinate
salt makes blood levels of this magnitude easily attainable.
Bacitracin diffuses readily when the meninges are inflamed but poorly
when they are normal."78 In contrast, isoniazid is widely distributed
throughout the body including the spinal fluid.' Measurement in a single*
patient with tuberculous meningitis suggested that hydrocortisone may
enter the cerebrospinal fluid more readily than normal in this infection.'
The levels of various drugs in the CSF should not be equated with those
of nervous tissue. A few studies which measure the passage of drugs into
the cerebral parenchyma have been done"'24"2 but simultaneous measure-
ments of drug levels in brain and cerebrospinal fluid have been limited and
more are needed.
C. Endogenous substances. As has been pointed out, inflammation not
only promotes the transport of foreign materials into the nervous system,
but also disturbs the equilibrium between substances normally present in
blood and spinal fluid. Among these are protein, sugars, organic acids, and
various inorganic ions.
1. Protein. Elevation of the cerebrospinal fluid protein is typical of bac-
terial meningitis. The nature and origin of this protein have not been
clearly defined. In the normal dog, there is active exchange of radioactive
iodinated serum albumin between the plasma protein pool and the spinal
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fluid.'9 These studies have not been performed in patients or animals with
bacterial meningitis. However, electrophoretic studies demonstrating an
increase in the cerebrospinal fluid albumin fraction in the early stages of
human meningitis suggest that infection increases meningeal permeability
to serum protein."01',l" "2 As the infection progressed, increases were noted
in all fractions of the cerebrospinal fluid globulin; with subsidence of men-
ingitis, the elevation became localized to the gamma globulin fraction.'
Increased vascular permeability and cellular breakdown have been held
to be the cause of the protein elevation in meningitis.' On the other hand,
a portion of this protein may emanate from nervous tissue per se. In sup-
port of this idea are the experiments of Mutermilch demonstrating the
capacity of the nervous system to form antibodies to sheep red cells given
intrathecally. "" Furthermore, elevation of the CSF gamma globulin with-
out concommitant increase of serum gamma globulin has been reported in
multiple sclerosis and central nervous system lues.' "19 Theincreased cerebro-
spinal fluid gamma globulin found late in meningitis may represent an
immune response of the nervous system.
Pertinent to this point is the observation that seronegative patients with
tuberculous, meningococcal, and lymphocytic nonbacterial meningitis occa-
sionally have a transiently positive Wasserman test in the CSF." This
suggests that under certain conditions neural tissues may elaborate a reagin
which combines with alcoholic beef heart extract. This hypothesis would
be more convincing were it not for the fact that some patients with sero-
positive latent lues also develop positive CSF complement fixation tests for
syphilis during the course of bacterial or viral meningitis. In these cir-
cumstances, passage of the reagin from blood to CSF must surely be a
consequence of a break in the blood-CSF barrier.
2. Sugar. A depressed spinal fluid sugar is the hall-mark of bacterial
meningitis. Hypoglycorrhachia of lesser degree has been described in
tuberculosis, syphilitic' and yeast meningitis, sarcoidosis of the nervous
system,14" diffuse leptomeningeal carcinomatosis,'4 4,''0 and subarachnoid
hemorrhage.' The low cerebrospinal fluid sugar is the single most impor-
tant difference between tuberculous and viral meningitis.
Normally the level of glucose in the spinal fluid closely parallels that
in the blood.4"67 For example, artificially induced hyperglycemia in man
and animals is accompanied by a rise in the cerebrospinal fluid sugar. It
is noteworthy, however, that the maximum increase in the cerebrospinal
fluid glucose is not observed for several hours following hypergly-
cemia."' 7' Conversely, hypoglycemia is associated with a fall in cerebro-
spinal fluid glucose."94
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The mechanism governing the disappearance of cerebrospinal fluid sugar
in bacterial meningitis has not been clearly elucidated, and the relative
importance of cells, bacteria, changes in meningeal permeability, and accel-
erated utilization by neural tissue in the genesis of hypoglycorrhachia re-
mains poorly defined. On the basis of existing evidence, however, certain
categorical statements can be made.
1. Clinical and experimental bacterial meningitis is characterized by a
pleocytosis, presence of bacteria, and a depression of spinal fluid
sugar.
2. This fall in cerebrospinal fluid sugar is not observed in aseptic or
viral meningitis despite the presence of leukocytes. This has been
established both in animals,"0'74' and in man.'
3. Incubation of sterile, cell-free spinal fluid at room and body tempera-
tures for prolonged periods has not been attended by a decrease in
sugar content.10's 6 81 82 i8
4. The addition of cells to sterile cerebrospinal fluid in vitro reduces
the amount of available sugar,0'" 81 82 8 126 and the degree of glycoly-
sis is directly proportional to the number of cells. Polymorphonuclear
leukocytes appear to utilize glucose more avidly than lympo-
cytes.
in, in2
5. When pneumococci were incubated in cell-free, sterile spinal fluid,
no glycolysis occurred unless the number of organisms far exceeded
that present in experimental infection in dogs.7' The in vitro utiliza-
tion of glucose in cerebrospinal fluid by several other bacterial species
has yielded inconsistent results.'0'61'8'
The discrepancy between the normal sugar levels in aseptic meningitis
and the capacity of leukocytes to utilize sugar in vitro has led to the sug-
gestion that the inflammatory process makes the meninges more permeable
to glucose. This in turn permits replenishment of cerebrospinal fluid glu-
cose from the blood. Another explanation which comes to mind is that
the exudate in most instances of aseptic meningitis consists predominantly
of lymphocytes which use but little glucose.
In view of the fact that bacteria are essential for hypoglycorrhachia
in vivo, it seems anomalous that the number of organisms necessary to
produce a comparable fall in vitro does not manifest itself in vivo. On the
basis of these experiments, one cannot attribute the decreased sugar in
meningitis to either cells or bacteria alone. It is conceivable that the glyco-
lytic power of bacteria may be enhanced by the presence of cells. This
has not been tested under experimental conditions in vitro. That it may
occur, however, can be discerned from recent studies of Petersdorf et al.
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who produced pneumococcal meningitis in dogs made leukopenic by total
body irradiation."48 These animals were unable to respond to the meningeal
infection with a pleocytosis and experienced no fall in cerebrospinal fluid
sugar despite the presence of a large number of organisms. Changes in
the permeability of the blood-cerebrospinal fluid barrier in this situation
are probably of minor consequence.
Some evidence exists that the blood-cerebrospinal fluid barrier may be
altered in the course of tuberculous meningitis. This is not unexpected in
the face of the slow utilization of glucose by the tubercle bacillus'l and the
predominantly lymphocytic response. Furthermore, sugar introduced intra-
thecally into patients with tuberculous meningitis disappears more rapidly
from the spinal fluid than could be explained by utilization by cells or acid-
fast bacilli.""'178'1" These investigations imply more rapid transfer of sugar
from the spinal fluid to the blood stream. It has also been noted that
hyperglycemia in tuberculous meningitis is paralleled by a rapid rise in
cerebrospinal fluid glucose, connoting a disruption of the blood-cerebro-
spinal fluid barrier.110
3. Organic metabolites. Lactic acid in the spinal fluid rises in purulent
meningitis and a variety of other conditions."1.1.198 The elevation appears
to vary directly with the cell count and correlates poorly with reduction
in the cerebrospinal fluid glucose. It seems likely that the organic acid is
a by-product of cellular breakdown."7"l'
Ethyl alcohol is increased in the spinal fluid of some patients with crypto-
coccal meningitis who also have a low cerebrospinal fluid sugar.17' This
ingenious observation, which facilitates the differentiation between tuber-
culous and cryptococcal meningitis, is based on the fact that ethanol is the
end product of glycolysis by yeast forms.
4. Inorganic ions. The decrease in the cerebrospinal fluid chloride in
meningitis is probably a reflection of the loss of this anion from the extra-
cellular fluid since the ratio of cerebrospinal fluid to blood chloride remains
fixed."' Cheek has suggested that the hypochloremia in tuberculous
meningitis is a consequence of metabolic alkalosis and hypotonic expansion
of the extracellular compartment.'2"m
The concentration of sodium in the spinal fluid is also dependent upon
the serum concentration. Experimental hypernatremia results in a rise
in cerebrospinal fluid sodium.' This may be a reflection of increased per-
meability since it has been demonstrated that hypernatremia in cats has
been associated with profound damage to neuronal tissue."' Further sup-
port for enhanced passage of sodium into the spinal fluid following menin-
geal injury may be adduced from the finding that cerebrospinal fluid levels
294
Volume 32, February 1960Pathogenesis of bacterial meningitis I HARTER, PETERSDORF
of radioactive sodium in tuberculous meningitis are higher than in con-
trols.' In contrast to sodium, potassium in the spinal fluid does not vary
with alterations of the serum potassium.' This cation has not been studied
in meningitis.
Elevations in the cerebrospinal fluid phosphorus have been reported in
meningitis,"0 "' as well as in a variety of other neurological disorders.'
Its significance is not known. There is a decrease in magnesium in the
cerebrospinal fluid of patients with chronic meningitis,' but calcium is
elevated."181 Both ionized and protein-bound calcium contribute to this
rise.
THE ROLE OF HOST FACTORS IN MENINGITIS
A. Anatomical and physiological defense mechanisms. Compared to other
bacterial infections, meningitis is a rare disease, and bacterial pathogens
isolated in meningitic infections much more frequently parasitize other
sites in the body. Of the bacteria most commonly found in meningitis only
Neisseria intracellularis exhibits particular affinity for the nervous system.
However, this organism is most often a benign commensal in the upper
respiratory tract and only rarely is a cause of clinical infection. The impli-
cations of these clinical observations are that the central nervous system
is extraordinarily well protected from infections, a most fortunate circum-
stance considering the high mortality and disastrous sequelae of meningitis.
Not the least important of these protective mechanisms is the anatomical
position of the nervous system. Encased by bone and connective tissue, it
is well shielded from external stimuli, including bacteria. In many in-
stances of meningitis, a specific disruption of this anatomical barrier such
as fracture, osteomyelitis, or dural tear can be demonstrated.
Functionally, the nervous system is also protected from invasion of
bacteria by unique filtering nmechanisms-the blood-CSF and blood-brain
barriers. As has been mentioned, these barriers are poorly defined anatomi-
cally and physiologically but there is little question about the remarkable
control which they exert upon the passage of metabolites into and out of the
nervous system. At the same time the entry of noxious substances appears
to be prevented. The precise alterations in these barriers in response to
infection remain ill defined but are probably most important.
B. Susceptibility of neuronal tissue. Little is known about the suscepti-
bility of neuronal tissue to bacterial infection. It is not known, for example,
whether there are factors indigenous to the cellular elements in the brain,
spinal cord, and meninges which make them react in a particular manner to
certain species of bacteria. B. lactis aerogenes has been said to be particu-
295YALE JOURNAL OF BIOLOGY AND MEDICINE
larly virulent for the meninges, but there is no evidence based upon in vitro
studies that this tissue supports the growth of the pathogen better than
others elsewhere in the body. Although poorly phagocytic normally, the
arachnoid lining cells are capable of transformation into effective phagocytes
under conditions of extreme irritation.' The nature of these irritating
stimuli has not been elucidated and, in general, little is known about the role
of phagocytosis in infections of the meninges. Lysozyme in the CSF is
known to be increased in bacterial meningitis; this is probably merely a
reflection of the presence of polymorphonuclear leukocytes, which are rich
in this enzyme."7 It is conceivable, however, that lysozyme is a product of
injury to nerve cells per se.
C. The inflammatory reaction in the meninges. W\Thile it seems clear that
there are potent defense mechanisms to prevent the entry of pathogenic
bacteria into the CNS, once infection is established host defenses are quite
inadequate. Proof of this statement lies in the high mortality prevalent prior
to the use of antibiotics. Even with appropriate chemotherapy and steriliza-
tion of the CSF, the mortality rate remains close to 25 per cent. The
mechanism of death in meningitis under these circumstances is not well
understood. Endocarditis and pneumonia may account for some therapeutic
failures; the majority, however, are probably related to the fact that the
inflammatory reaction, normally an important cog in the defense to infection,
may be distinctly deleterious in the cranial cavity. In most loci the inflamma-
tory exudate or pus is easily removed by drainage, expectoration, or micturi-
tion depending upon the site of the infection. These avenues of escape are not
available in acute leptomeningitis, and resolution and absorption of inflam-
matory cells are the only means for recovery. Failure to remove the exudate
may result in an increase in intracranial pressure or development of sub-
arachnoid block, either of which can be fatal. Inflammatory exudates may
also adversely influence the action of antibiotics; Wood and Smith demon-
strated in experimental pneumococcal pneumonia that antimicrobial activity
was greater at theperiphery of the lesion, where bacteria were actively multi-
plying and cellular exudation was sparse, than in the center loaded with
masses of inflammatory cells and dead organisms."95
ACTH and cortisone have been employed in bacterial meningitis to miti-
gate the inflammatory response and to prevent some of these complications.
Ribble and Braude reported recovery in 11 of 12 patients with pneumococcal
meningitis treated with penicillin and adrenal cortical hormones, a thera-
peutic result superior to any group treated with penicillin alone.' However,
this study contained no controls. More recently, Lepper and Spies treated
alternate patients with pneumococcal meningitis with adrenal steroids and
penicillin and were unable to demonstrate that the hormones exerted a
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beneficial effect."' There seems to be little doubt that adrenal steroids have
favorably affected the course of tuberculous meningitis and should be used
in addition to chemotherapy.' In the face of these inconclusive data the
effectiveness of adrenal hormones as therapeutic adjuncts must remain sub
judice. There is good theoretical basis for their use not only to minimize the
inflammatory response but also to modify the acute hypersensitivity reaction
to bacterial products which may play a role in some types of bacterial
meningitis (vide infra). Further therapeutic trials with adrenal hormones
seem indicated particularly since it appears that they are not harmful in
acute bacterial infections of man when proper antibiotics are administered.'76
The instillation of the proteolytic enzymes, streptokinase-dornase, into the
subarachnoid space to aid in resolution of the thick proteinaceous exudate
has received wide attention. The results have not been impressive and some-
times the constitutional reaction to these drugs has been extraordinarily
severe. In a recent enthusiastic report Tillet described the action of these
enzymes in pneumococcal meningitis.'
D. The allergic response of the meninges. The capacity of the meninges to
manifest "delayed hypersensitivity" in the form of an acute exudative
reaction suggests that this may be an important mechanism in the develop-
ment of increased intracranial pressure and subarachnoid block. Burn and
Finley produced a severe exudative meningitis in guinea pigs with visceral
tuberculosis by the intrathecal administration of tuberculoprotein; normal
controls did not become ill.' These experiments were the forerunner of
those of Swithbank, Smith, and Vollman who described an acute non-
bacterial meningitis in Mantoux-positive patients given PPD intrathecally."7
Clinically, these patients, who were described as having an "intrathecal
tuberculin reaction," developed fever, headache, and nuchal rigidity. The
CSF showed pleocytosis and elevation in protein, and the blood-CSF barrier
became more permeable to bromide.' The intensity of the response was
directly proportional to the amount of tuberculin administered and the
sensitivity of the host; Mantoux-negative individuals did not develop
meningitis, and, conversely, the severity of the reaction was ameliorated
following desensitization. There is little doubt that the intrathecal tuberculin
reaction is an allergic response of the meninges. Whether it of any impor-
tance in tuberculous meningitis or whether delayed hypersensitivity to other
bacteria is responsible for the formation of exudate in the subarachnoid
space is not known. Exudation produced in this manner may not be entirely
detrimental since, in some instances at least, intrathecal tuberculin has been
effective in relieving subarachnoid block in patients with tuberculous
meningitis.5 '
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E. Immunity. The role of specific immunity in bacterial meningitis has
been studied extensively. In the pre-antibiotic era, introduction of specific
antisera into the subarachnoid space was of some benefit in experimental
meningococcal, pneumococcal, and hemophilus meningitis.',''o'" With the
exception of some enthusiastic reports,""M the results in man were unim-
pressive."' There is some evidence that the combination of specific rabbit
antiserum and sulfonamides exerted a synergistic effect in hemophilus
infection of the meninges.19
Normally, there is little or no transfer of antibody from the blood into the
spinal fluid.'
'-' Using a more sensitive technique, Freund demonstrated
antibody in the CSF of rabbits actively and passively immunized with
typhoid bacilli.' The ratio of blood to CSF antibody titers in actively
immunized animals was 300: 1, which was quantitatively similar to the ratio
of serum to CSF gamma globulin determined by electrophoretic techniques.9'
The blood-CSF and blood-brain barriers may differ in their permeability to
immune particles, and the localization of antibody in the brain is not neces-
sarily accompanied by a rise of the same antibody in the spinal fluid."7
Passage of antibody into the CSF is enhanced during aseptic meningitis
and has been demonstrated for neutralizing substances to poliomyelitis"
and meningococcal agglutinins.3 Similarly, hemolysins to sheep red cells and
complement have also been found in the CSF of patients with meningitis,
but not in normals.
m
In view of the precipitous onset and brief duration of bacterial menin-
gitides, active immunity may not beacquired in time to influence the outcome
of these acute infections. Furthermore, as in subacute bacterial endocarditis,
patients with bacterial meningitis may have antibodies to the offending
pathogen in the circulation. This suggests that antibody does not reach
adequate concentration in the CSF, even in meningitis. An alternative
explanation, suggested by the relative ineffectiveness of antisera thera-
peutically, is that the subarachnoid space provides a poor environment for
the action of antibody.
There is a considerable body of evidence, however, that acquired immunity
is an important factor in man's resistance to meningitis. Specific examples
are furnished by H. influenzae meningitis which is confined almost exclu-
sively to children between 3 and 18 months of age. Fothergill tested blood
from newborns and children of various ages for bactericidal activity against
H. influenzae and demonstrated that blood from infants under two months
and children older than three years killed the organisms regularly, while that
obtained from children between these ages was but weakly bactericidal."
Susceptibility of infants to H. influenzae meningitis appears to be directly
related to the absence of antibody and with the development of active
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immunity, presumably on repeated exposure to the organism in the respira-
tory tract, the host is afforded almost permanent protection from infection
with this bacterium. Similarly, the occurrence of meningococcal meningitis is
largely determined by the inmmune state of the host. A case in point is the
relatively high incidence of this disease in unseasoned Army recruits. In
contrast, clinical cases are extremely rare in sailors at sea where the popula-
tion turn-over is low."' Acquisition of specific immunity appears to be
instrumental in preventing second attacks of meningococcal and hemophilus
meningitis which are quite rare. In fact, most recurrent attacks of bacterial
meningitis are caused by pneumococcus and, even in this situation, different
types are usually incriminated.81b
There is a group of conditions in which man appears peculiarly vulnerable
to meningeal infections. Among these are congenital and acquired agamma-
globulinemia, in which there appears to be a tendency to develop coccal
meningitis,"' multiple myeloma, which is frequently complicated by pneumo-
coccal infections including meningitis, and surgical or congenital absence of
the spleen, in which pneumococcal meningitis has been a frequent occur-
rence.72a 87a,158b In the first two instances, gamma globulin is diminished or
functionally defective, and antibody production is markedly impaired. The
reason for susceptibility of splenectomized children to infection in general,
and meningitis in particular, is not readily apparent. These patients are
capable of synthesizing gamma globulin normally, and the concentration of
this protein fraction in the serum is normal or elevated. Furthermore, they
have a normal response following a provocative dose of diphtheria toxoid.b
On the other hand, Rowley demonstrated that splenectomized patients
failed to respond with a significant titer following the intravenous admin-
istration of sheep erythrocytes. a challenge which was regularly associated
with a brisk antibody response in normal experimental subjects."
It is fair to say, on the basis of these observations, that immune processes
are of considerable importance in determining man's susceptibility to menin-
geal infection. The precise conditions under which these protective mechan-
isms are operative and the stimuli evoking the appearance of antibody in the
nervous system remain subjects for further investigation.
F. Fever. Elevation of body temperature does little to disturb the
equilibrium between the brain and CSF and the rest of the body unless
extreme heights are reached. No change in radioactive phosphorus exchange
was found in rabbits with temperatures ranging between 38.2 C. and
41.0 C.' Earlier studies indicated that permeability to bismuth and hemoly-
sins to sheep red cells, but not trypan blue, was increased in rabbits with
fevers of 42 C.-43 C.' In man, elevation of the temperature to 106 F. for
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30 minutes on five consecutive days resulted in an increased transfer of
bromide from blood to CSF.l"
Whether the blood brain barrier is permeable to substances which are
themselves capable of producing fever has been the subject of considerable
study."' There is some evidence that endogenous pyrogen, which is pre-
sumably the end-product of cellular injury by a variety of pyrogenic stimuli,
gains access to the meninges with ease; in contrast, bacterial endotoxins
which consist of large lipopolysaccharide molecules gain entry into the CNS
only after a considerable delay. King and Wood have interpreted these data
to mean that endogenous pyrogen is the substance responsible for activating
the thermoregulatory centers,99 but there are also experiments which suggest
that, in the absence of endogenous pyrogen, bacterial endotoxins may affect
these centers directly."'
COMMENT
It seems clear that a review of this nature will pose more questions than it
answers. Without reiterating any specific points, it is still not clear how
microorganisms enter the meninges, how infections begin, and what defenses
the host mobilizes to combat infection. The unique behavior of various
species of bacteria, the mechanisms governing the biochemical alterations in
the spinal fluid, and the role of normal constituents of the body fluids in
meningeal infection remain unsolved. Entirely shrouded in mystery are the
nature of the histochemical and enzymatic defects which must be a part of
the profound inflammatory reaction. More pragmatically, the mechanism of
death occurring in the face of a bacteriologically sterile spinal fluid remains
undefined. If this report has stimulated sufficient interest in these biological
phenomena to promote a return of the subject of bacterial meningitis fromn
the historical library to the laboratory, it will have served its purpose.
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